Vitamin D: Immuno-modulation and tuberculosis treatment

Area of Science:

• Immunology
• Nutritional Science
• Infectious Diseases

Background:

• Tuberculosis (TB) is a significant global health issue often linked with vitamin D deficiency.
• Vitamin D plays a crucial role in immune function, acting via the vitamin D receptor (VDR).
• VDR gene polymorphisms influence TB susceptibility and treatment outcomes.

Purpose of the Study:

• To explore the role of vitamin D in innate immunity against Mycobacterium tuberculosis.
• To evaluate the potential benefits of vitamin D supplementation as an adjunct TB therapy.
• To address conflicting results from previous clinical trials on vitamin D for TB.

Main Methods:

• In-vitro studies demonstrating vitamin D's enhancement of antimicrobial peptide expression and autophagy.
• Review of clinical trials assessing vitamin D supplementation in TB patients.
• Analysis of vitamin D's immunomodulatory effects on pro-inflammatory and anti-inflammatory responses.

Main Results:

• 1,25-dihydroxyvitamin D3 enhances innate immunity by increasing antimicrobial peptides and autophagy, restricting intracellular M. tuberculosis growth.
• Vitamin D modulates immune responses, suppressing pro-inflammatory cytokines and promoting anti-inflammatory effects.
• Clinical trials show conflicting results regarding vitamin D supplementation efficacy due to varied protocols.

Conclusions:

• Vitamin D supplementation alongside TB treatment may mitigate tissue damage during active disease.
• Optimal vitamin D concentrations for adjunct TB therapy require further investigation.
• Standardized research is needed to optimize vitamin D's role in managing both drug-sensitive and drug-resistant TB.